Initial Virologic Response and HIV Drug Resistance Among HIV-Infected Individuals Initiating First-line Antiretroviral Therapy at 2 Clinics in Chennai and Mumbai, India

Hingankar, Nitin K.; Thorat, Smita R.; Deshpande, Alaka; Rajasekaran, S.; Chandrasekar, C.; Kumar, Suria; Srikantiah, Padmini; Chaturbhuj, Devidas N.; Datkar, Sharda R.; Deshmukh, Pravin S.; Kulkarni, Smita S.; Sane, Suvarna; Reddy, D. C. S.; Garg, Renu; Jordan, Michael R.; Kabra, Sandhya; Tripathy, Srikanth P.; Paranjape, Ramesh S.
May 2012
Clinical Infectious Diseases;May2012 Supplement 4, Vol. 54 Issue suppl_4, pS348
Academic Journal
Human immunodeficiency virus drug resistance (HIVDR) in cohorts of patients initiating antiretroviral therapy (ART) at clinics in Chennai and Mumbai, India, was assessed following World Health Organization (WHO) guidelines. Twelve months after ART initiation, 75% and 64.6% of participants at the Chennai and Mumbai clinics, respectively, achieved viral load suppression of <1000 copies/mL (HIVDR prevention). HIVDR at initiation of ART (P <.05) and 12-month CD4 cell counts <200 cells/μL (P <.05) were associated with HIVDR at 12 months. HIVDR prevention exceeded WHO guidelines (≥70%) at the Chennai clinic but was below the target in Mumbai due to high rates of loss to follow-up. Findings highlight the need for defaulter tracing and scale-up of routine viral load testing to identify patients failing first-line ART.


Related Articles

  • The Global Status of HIV Drug Resistance: Clinical and Public-Health Approaches for Detection, Treatment and Prevention. Hong, Steven Y.; Nachega, Jean B.; Kelley, Karen; Bertagnolio, Silvia; Marconi, Vincent C.; Jordan, Michael R. // Infectious Disorders - Drug Targets;Apr2011, Vol. 11 Issue 2, p124 

    No abstract available.

  • Implementing Early-Warning Indicators of HIV Drug Resistance in the Caribbean. Jack, Noreen; Ravasi, Giovanni; Schrooten, Ward; Sutherland, Donald; Ghidinelli, Massimo; Del Riego, Amalia // Clinical Infectious Diseases;May2012 Supplement 4, Vol. 54 Issue suppl_4, pS290 

    A key component of the World Health Organization’s (WHO’s) Global HIV Drug Resistance (HIVDR) prevention and assessment strategy is to monitor HIVDR early-warning indicators (EWIs), which provide strategic information for HIVDR containment. The Pan American Health Organization...

  • Early Warning Indicators for Population-Based Monitoring of HIV Drug Resistance in 6 African Countries. Sigaloff, Kim C. E.; Hamers, Raph L.; Menke, Jack; Labib, Moheb; Siwale, Margaret; Ive, Prudence; Botes, Mariette E.; Kityo, Cissy; Mandaliya, Kishor; Wellington, Maureen; Osibogun, Akin; Geskus, Ronald B.; Stevens, Wendy S.; van Vugt, Michèle; Rinke de Wit, Tobias F. // Clinical Infectious Diseases;May2012 Supplement 4, Vol. 54 Issue suppl_4, pS294 

    Human immunodeficiency virus (HIV) RNA testing and HIV drug resistance (HIVDR) testing are not routinely available for therapeutic monitoring of patients receiving antiretroviral therapy (ART) in resource-limited settings. World Health Organization HIVDR early warning indicators (EWIs) assess...

  • A Retrospective Survey of HIV Drug Resistance Among Patients 1 Year After Initiation of Antiretroviral Therapy at 4 Clinics in Malawi. Wadonda-Kabondo, Nellie; Hedt, Bethany L.; van Oosterhout, Joep J.; Moyo, Kundai; Limbambala, Eddie; Bello, George; Chilima, Ben; Schouten, Erik; Harries, Anthony; Massaquoi, Moses; Porter, Carol; Weigel, Ralf; Hosseinipour, Mina; Aberle-Grasse, John; Jordan, Michael R.; Kabuluzi, Storn; Bennett, Diane E. // Clinical Infectious Diseases;May2012 Supplement 4, Vol. 54 Issue suppl_4, pS355 

    In 2004, Malawi began scaling up its national antiretroviral therapy (ART) program. Because of limited treatment options, population-level surveillance of acquired human immunodeficiency virus drug resistance (HIVDR) is critical to ensuring long-term treatment success. The World Health...

  • HIV Drug Resistance Early Warning Indicators in Cohorts of Individuals Starting Antiretroviral Therapy Between 2004 and 2009: World Health Organization Global Report From 50 Countries. Bennett, Diane E.; Jordan, Michael R.; Bertagnolio, Silvia; Hong, Steven Y.; Ravasi, Giovanni; McMahon, James H.; Saadani, Ahmed; Kelley, Karen F. // Clinical Infectious Diseases;May2012 Supplement 4, Vol. 54 Issue suppl_4, pS280 

    The World Health Organization developed a set of human immunodeficiency virus drug resistance (HIVDR) early warning indicators (EWIs) to assess antiretroviral therapy clinic and program factors associated with HIVDR. EWIs are monitored by abstracting data routinely recorded in clinical records,...

  • Long-term maraviroc use as salvage therapy in HIV-2 infection. Caixas, Umbelina; Ferreira, Joana; Marinho, Aline T.; Faustino, Inês; Grilo, Nádia M.; Lampreia, Fátima; Germano, Isabel; Monteiro, Emília C.; Pereira, Sofia A. // Journal of Antimicrobial Chemotherapy (JAC);Oct2012, Vol. 67 Issue 10, p2538 

    The article discusses the case of a patient diagnosed with human immunodeficiency virus (HIV)-2. Information on the patient's combined antiretroviral therapy (cART) is provided. Atazanavir/ritonavir served as substitutes to lopinavir/ritonavir due to the patient's intolerance and poor adherence...

  • Drug-resistant HIV test boosts therapy. Tanday, Sanjay // GP: General Practitioner;1/12/2007, p2 

    The article reports that according to a new study, a test that can identify drug-resistant strains of HIV in a patient's blood could boost therapy success. The parallel allele-specific sequencing assay was found to be 1,000 times more sensitive than tests currently used to determine drug...

  • Prevalence of Genotypic Resistance in Untreated HIV Patients in Spain. Eiros, J. M.; Labayru, C.; Hernández, B.; Ortega, M.; Bachiller, P.; de Lejarazu, R. Ortiz // European Journal of Clinical Microbiology & Infectious Diseases;Apr2002, Vol. 21 Issue 4, p310 

    The aims of this retrospective study were to assess the prevalence of primary genotypic resistance to antiretroviral drugs in untreated HIV patients in Spain using the line probe assay and to determine its possible relationship to several epidemiological variables. The global prevalence of...

  • Characterization of HIV-1 Genotypes and Antiretroviral Drug-resistance Mutations among Patients in Burkina Faso. Kagone, T. S.; Hien, H.; Meda, N.; Diagbouga, P. S.; Sawadogo, A.; Drabo, J.; Peeters, M.; Vergne, L.; Delaporte, E.; De Souza, C.; Gbeassor, M.; Simpore, J. // Pakistan Journal of Biological Sciences;2011, Vol. 14 Issue 6, p392 

    No abstract available.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics